{{Rsnum
|rsid=783147
|Gene=PLG
|Chromosome=6
|position=160716958
|Orientation=minus
|GMAF=0.4114
|Gene_s=PLG
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 36.3 | 40.7 | 23.0
| HCB | 29.2 | 46.0 | 24.8
| JPT | 21.2 | 49.6 | 29.2
| YRI | 63.3 | 29.9 | 6.8
| ASW | 64.9 | 31.6 | 3.5
| CHB | 29.2 | 46.0 | 24.8
| CHD | 22.0 | 56.0 | 22.0
| GIH | 36.6 | 42.6 | 20.8
| LWK | 70.9 | 29.1 | 0.0
| MEX | 19.0 | 53.4 | 27.6
| MKK | 64.7 | 29.5 | 5.8
| TSI | 30.4 | 52.0 | 17.6
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=21900290
|Trait=None
|Title=Genetic variants, plasma lipoprotein(a) levels, and risk of cardiovascular morbidity and mortality among two prospective cohorts of type 2 diabetes.
|RiskAllele=A
|Pval=3E-17
|OR=0.3000
|ORtxt=[0.22-0.38] mg/dL decrease
|OA=1
}}

{{PMID Auto
|PMID=21078622
|Title=Conventional and Mendelian randomization analyses suggest no association between lipoprotein(a) and early atherosclerosis: the Young Finns Study.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}